Economic Evaluation of Rotavirus Vaccination in Children Aged Under Five Years in South Africa

Cost-effectiveness analysis measuring the total costs against the health benefits of three different rotavirus vaccines for Mexico

(2023) Jorge Gomez et al.   Human Vaccines & Immunotherapeutics

Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi

(2022) Fulgence Niyibitegeka et al.   Applied Health Economics and Health Policy

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study

(2021) Frédéric Debellut et al.   Lancet Global Health

Changing Inequalities in Health-Adjusted Life Expectancy by Income and Race in South Africa

(2021) Caryn Bredenkamp et al.   Health Systems & Reform

Prevalence, Pattern and Genetic Diversity of Rotaviruses among Children under 5 Years of Age with Acute Gastroenteritis in South Africa: A Systematic Review and Meta-Analysis

(2021) Cornelius A. Omatola et al.   Viruses-Basel

Estimating a cost-effectiveness threshold for health care decision-making in South Africa

(2020) Ijeoma P Edoka et al.   HEALTH POLICY AND PLANNING

Systematic Review and Meta-analysis of Cost-effectiveness of Rotavirus Vaccine in Low and Low-Middle Income Countries

(2019) Sabbir Haider et al.   Open Forum Infectious Diseases

Rotavirus Vaccines: Effectiveness, Safety, and Future Directions

(2018) Eleanor Burnett et al.   PEDIATRIC DRUGS

Temporal association of rotavirus vaccination and genotype circulation in South Africa: Observations from 2002 to 2014

(2017) N.A. Page et al.   VACCINE

Rotavirus infection

(2017) Sue E. Crawford et al.   Nature Reviews Disease Primers

Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study

(2014) Michelle J Groome et al.   LANCET INFECTIOUS DISEASES

Cost-effectiveness analysis of rotavirus vaccination among Libyan children using a simple economic model

(2014) Salem Alkoshi et al.   Libyan Journal of Medicine

Impact of Rotavirus Vaccine on Childhood Diarrheal Hospitalization After Introduction Into the South African Public Immunization Program

(2013) Veerle M. Y. Msimang et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Self-Reported Population Health: An International Perspective Based on EQ-5D

(2013) A. Szende et al.   VALUE IN HEALTH

Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France

(2013) Baudouin Standaert et al.   Applied Health Economics and Health Policy

Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial

(2012) Andrew Duncan Steele et al.   BMC INFECTIOUS DISEASES

Rotavirus vaccination: a concise review

(2012) T. Vesikari   CLINICAL MICROBIOLOGY AND INFECTION

Estimating and comparing the clinical and economic impact of paediatric rotavirus vaccination in Turkey using a simple versus an advanced model

(2012) Mustafa Bakir et al.   VACCINE

Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland

(2011) L. Tilson et al.   VACCINE

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

(2010) Shabir A. Madhi et al.   NEW ENGLAND JOURNAL OF MEDICINE

An update to “The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe”

(2010) Mark Jit et al.   VACCINE

Estimating utility scores in young children with acute rotavirus gastroenteritis in the UK

(2010) Alan Martin et al.   JOURNAL OF MEDICAL ECONOMICS